Atypical Femur Fractures in Patients Treated with Bisphosphonates: Identification, Management, and Prevention
Osteoporosis is a common condition with significant health care costs. First-line therapy is with bisphosphonates, which have proven anti-fracture efficacy. Around 10 years after the introduction of bisphosphonates reports began to be published of atypical femoral fractures (AFFs) that may be associ...
Main Author: | Judith Sarah Bubbear |
---|---|
Format: | Article |
Language: | English |
Published: |
Rambam Health Care Campus
2016-10-01
|
Series: | Rambam Maimonides Medical Journal |
Subjects: | |
Online Access: | http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=633 |
Similar Items
-
Bilateral atypical fractures of the femur: Ten years AFTER ten years of bisphosphonate therapy
by: Matthew D. Smith, et al.
Published: (2021-12-01) -
Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
by: Francisco Bandeira, et al.
Published: (2020-07-01) -
Atypical femur fractures associated with chronic bisphosphonates use: A case series with 66 patients
by: Guilherme Guadagnini Falotico, et al.
Published: (2022-11-01) -
Bisphosphonate-induced atypical femoral shaft fracture: A case report
by: Ameer Mustafa Farrukh, et al.
Published: (2023-11-01) -
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
by: Joan C. Lo, et al.
Published: (2020-12-01)